General Information of the Compound
| Compound ID |
CP0575185
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(4S)-4-[[3-methyl-5-[5-[2-methyl-6-(propan-2-ylamino)pyridin-4-yl]-1,2,4-oxadiazol-3-yl]pyrazin-2-yl]oxymethyl]-1,3-oxazolidin-2-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H23N7O4
|
||||||||||||||||||
| Molecular Weight |
425.449
|
||||||||||||||||||
| Canonical SMILES |
CC(C)Nc1cc(cc(C)n1)-c1nc(no1)-c1cnc(OC[C@H]2COC(=O)N2)c(C)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H23N7O4/c1-10(2)22-16-6-13(5-11(3)23-16)19-26-17(27-31-19)15-7-21-18(12(4)24-15)29-8-14-9-30-20(28)25-14/h5-7,10,14H,8-9H2,1-4H3,(H,22,23)(H,25,28)/t14-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
HIWNLCVVOZWAKB-AWEZNQCLSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound